Selected products and researched market regarding suppliers — Studied market
for availability of products and ordering information.
Speaking of reaching the hands of consumers, there is no information on the company's website
for the availability of this product.
«We usually look
for the availability of product, and then focus in on an area.»
Not exact matches
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability
of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential
for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost
of accommodating, announced increases in the build rates
of certain aircraft; 6) the effect on aircraft demand and build rates
of changing customer preferences
for business aircraft, including the effect
of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result
of global economic uncertainty or otherwise; 8) the effect
of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution
of key milestones such as the receipt
of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals
for the consummation
of our announced acquisition
of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability
of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk
of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production
of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts
of terrorism; 14) any adverse impact on the demand
for air travel or our operations from the outbreak
of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact
of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price
for our announced acquisition
of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect
of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect
of changes in tax law, such as the effect
of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations
of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect
of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and
availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass
of highly - skilled employees and our relationships with the unions representing many
of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate
for our additional capital needs or
for payment
of interest on, and principal
of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness
of any interest rate hedging programs; 28) the effectiveness
of our internal control over financial reporting; 29) the outcome or impact
of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential
product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition
of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions
for ourselves and Asco as a result
of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks
of doing business internationally, including fluctuations in foreign current exchange rates, impositions
of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
Such risks, uncertainties and other factors include, without limitation: (1) the effect
of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity prices, interest rates and foreign currency exchange rates, levels
of end market demand in construction and in both the commercial and defense segments
of the aerospace industry, levels
of air travel, financial condition
of commercial airlines, the impact
of weather conditions and natural disasters and the financial condition
of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization
of the anticipated benefits
of advanced technologies and new
products and services; (3) the scope, nature, impact or timing
of acquisition and divestiture or restructuring activity, including the pending acquisition
of Rockwell Collins, including among other things integration
of acquired businesses into United Technologies» existing businesses and realization
of synergies and opportunities
for growth and innovation; (4) future timing and levels
of indebtedness, including indebtedness expected to be incurred by United Technologies in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection with the pending Rockwell Collins acquisition; (5) future
availability of credit and factors that may affect such
availability, including credit market conditions and our capital structure; (6) the timing and scope
of future repurchases
of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level
of other investing activities and uses
of cash, including in connection with the proposed acquisition
of Rockwell; (7) delays and disruption in delivery
of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits
of organizational changes; (11) the anticipated benefits
of diversification and balance
of operations across
product lines, regions and industries; (12) the outcome
of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact
of the negotiation
of collective bargaining agreements and labor disputes; (15) the effect
of changes in political conditions in the U.S. and other countries in which United Technologies and Rockwell Collins operate, including the effect
of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates in the near term and beyond; (16) the effect
of changes in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act
of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations in the U.S. and other countries in which United Technologies and Rockwell Collins operate; (17) the ability
of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result in the imposition
of conditions that could adversely affect the combined company or the expected benefits
of the merger) and to satisfy the other conditions to the closing
of the pending acquisition on a timely basis or at all; (18) the occurrence
of events that may give rise to a right
of one or both
of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee
of $ 695 million to United Technologies or $ 50 million
of expense reimbursement; (19) negative effects
of the announcement or the completion
of the merger on the market price
of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation
of their businesses while the merger agreement is in effect; (21) risks relating to the value
of the United Technologies» shares to be issued in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability
of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.
The biggest one to date
for a biosimilar
product in the U.S. — the treatments have only been around
for a handful
of years in America despite widespread and long - standing
availability in Europe and other regions — Renflexis may ultimately not do much to curb health care and patient spending, as the Wall Street Journal «s Charley Grant points out in an astute note.
Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, and capital markets conditions and other factors beyond the Company's control, including natural and other disasters or climate change affecting the operations
of the Company or its customers and suppliers; (2) the Company's credit ratings and its cost
of capital; (3) competitive conditions and customer preferences; (4) foreign currency exchange rates and fluctuations in those rates; (5) the timing and market acceptance
of new
product offerings; (6) the
availability and cost
of purchased components, compounds, raw materials and energy (including oil and natural gas and their derivatives) due to shortages, increased demand or supply interruptions (including those caused by natural and other disasters and other events); (7) the impact
of acquisitions, strategic alliances, divestitures, and other unusual events resulting from portfolio management actions and other evolving business strategies, and possible organizational restructuring; (8) generating fewer productivity improvements than estimated; (9) unanticipated problems or delays with the phased implementation
of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; and (11) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form 10 - K
for the year ended Dec. 31, 2017, and any subsequent quarterly reports on Form 10 - Q (the «Reports»).
Shayla, who also had to mix shades to find her match, later said that she actually liked the
product's consistency, but that she considered her favorable impression
of the
product itself «kind
of a shame» due to its lack
of availability for other people
of darker complexions.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues
for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement
for new
products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount
of discount required on Gilead's
products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration;
availability of funding
for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction
of generic versions
of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect
of lowering prices or reducing the number
of insured patients; the possibility
of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels
of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits
of the Sangamo partnership; Gilead's ability to submit new drug applications
for new
product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all,
for new and current
products, including Biktarvy; Gilead's ability to successfully commercialize its
products, including Biktarvy; the risk that physicians and patients may not see advantages
of these
products over other therapies and may therefore be reluctant to prescribe the
products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development
of Gilead's
product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate
of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Factors that could cause actual results to differ include general business and economic conditions and the state
of the solar industry; governmental support
for the deployment
of solar power; future available supplies
of high - purity silicon; demand
for end - use
products by consumers and inventory levels
of such
products in the supply chain; changes in demand from significant customers; changes in demand from major markets such as Japan, the U.S., India and China; changes in customer order patterns; changes in
product mix; capacity utilization; level
of competition; pricing pressure and declines in average selling prices; delays in new
product introduction; delays in utility - scale project approval process; delays in utility - scale project construction; delays in the completion
of project sales; continued success in technological innovations and delivery
of products with the features customers demand; shortage in supply
of materials or capacity requirements;
availability of financing; exchange rate fluctuations; litigation and other risks as described in the Company's SEC filings, including its annual report on Form 20 - F filed on April 27, 2017.
Factors that could cause actual results to differ include general business and economic conditions and the state
of the solar industry; governmental support
for the deployment
of solar power; future available supplies
of high - purity silicon; demand
for end - use
products by consumers and inventory levels
of such
products in the supply chain; changes in demand from significant customers; changes in demand from major markets such as Japan, the U.S., India and China; changes in customer order patterns; changes in
product mix; capacity utilization; level
of competition; pricing pressure and declines in average selling prices; delays in new
product introduction; delays in utility - scale project approval process; delays in utility - scale project construction; continued success in technological innovations and delivery
of products with the features customers demand; shortage in supply
of materials or capacity requirements;
availability of financing; exchange rate fluctuations; litigation and other risks as described in the Company's SEC filings, including its annual report on Form 20 - F filed on April 20, 2016.
Factors that could cause actual results to differ include general business and economic conditions and the state
of the solar industry; governmental support
for the deployment
of solar power; future available supplies
of high - purity silicon; demand
for end - use
products by consumers and inventory levels
of such
products in the supply chain; changes in demand from significant customers; changes in demand from major markets such as Japan, the U.S., India and China; changes in customer order patterns; changes in
product mix; capacity utilization; level
of competition; pricing pressure and declines in average selling prices; delays in new
product introduction; delays in utility - scale project approval process; delays in utility - scale project construction; cancelation
of utility - scale feed - in - tariff contracts in Japan; continued success in technological innovations and delivery
of products with the features customers demand; shortage in supply
of materials or capacity requirements;
availability of financing; exchange rate fluctuations; litigation and other risks as described in the Company's SEC filings, including its annual report on Form 20 - F filed on April 27, 2017.
Please consult your own professional adviser
for further information on
availability of products and services in your jurisdiction.
Play on these emotions by offering specials within the holiday season, whether it's 24 - hour - only coupon codes
for online purchases, the creation
of limited - time - only gift basket
availability or a limit on the number
of buy - one - get - one - free deals you'll offer on a certain
product.
We caution you that these statements are not guarantees
of future performance and are subject to numerous risks and uncertainties, including volatility in the economy and the credit markets, supply and demand changes
for vacation ownership and residential
products, competitive conditions; the
availability of capital to finance growth, and other matters referred to under the heading «Risk Factors» contained in our Annual Report on 10 - K
for the year ended December 30, 2011 filed with the U.S. Securities and Exchange Commission (the «SEC») and in subsequent SEC filings, any
of which could cause actual results to differ materially from those expressed in or implied in this presentation.
U.S. Bank is not responsible
for the content
of, or
products and services provided by FINRA, nor does it guarantee the system
availability or accuracy
of information contained in the site.
But it's still important to evaluate all components
of a mortgage company, including rates, customer service and loan
product availability when choosing the best option
for you.
The
availability of a streamlined version
of the exemption
for level - fee advisors makes selling fee - based
products more attractive
for advisory firms, which can be held liable
for advisors who, as DOL fiduciaries, sell
products that are not in the client's best interests.
These risks and uncertainties include: fluctuations in U.S. and international economies and currencies, our ability to preserve, grow and leverage our brands, potential negative effects
of material breaches
of our information technology systems if any were to occur, costs associated with, and the successful execution
of, the company's initiatives and plans, the acceptance
of the company's
products by our customers, the impact
of competition, coffee, dairy and other raw material prices and
availability, the effect
of legal proceedings, and other risks detailed in the company filings with the Securities and Exchange Commission, including the «Risk Factors» section
of Starbucks Annual Report on Form 10 - K
for the fiscal year ended September 28, 2014.
While much
of the loosening has been
for jumbo loan
products, the
availability of conforming conventional mortgage credit has also somewhat increased...»
We caution you that these statements are not guarantees
of future performance and are subject to numerous risks and uncertainties, including volatility in the economy and the credit markets, supply and demand changes
for vacation ownership and residential
products, competitive conditions; the
availability of capital to finance growth, and other matters referred to under the heading «Risk Factors» contained in the Information Statement filed as an exhibit to our Annual Report on Form 10 - K
for the year ended December 30, 2011 filed with the U.S. Securities and Exchange Commission (the «SEC») and in subsequent SEC filings, any
of which could cause actual results to differ materially from those expressed in or implied in this presentation.
The company cautions you that these statements are not guarantees
of future performance and are subject to numerous risks and uncertainties, including volatility in the economy and the credit markets, supply and demand changes
for vacation ownership and residential
products, competitive conditions; the
availability of capital to finance growth, and other matters referred to under the heading «Risk Factors» contained in the company's most recent Annual Report on Form 10 - K filed with the U.S Securities and Exchange Commission (the «SEC») and in subsequent SEC filings, any
of which could cause actual results to differ materially from those expressed in or implied in this press release.
Shopping patterns on Tmall.com, China's largest shopping website
for authentic branded goods, demonstrate that consumers especially seek out imported brands
for several reasons including better quality,
product safety, lack
of domestic
availability, and lower prices.
«The demographics
of the online shopper align well with the natural and organic consumer, and the convenience and wider
availability of products online appeals to an increasing number
of consumers, helping to expand the reach
of for better -
for - you
product options.»
This may not be feasible
for many consumers due to cost implications, compliance issues and
availability of enriched
products.
The report notes, «Shoppers say
product availability is a top - three reason
for where they shop, yet on average, every time a shopper comes into a store, one out
of every 12 items on her shopping list, and one out
of every 10 or less
for promoted items, is not on the shelf.»
New
product development in the pizza category has a sharp focus on authentic, restaurant - quality
products suitable to share with family and friends and available
for impulse or advance purchase.2 The wide retail
availability of ready - to - bake frozen and chilled fresh pizzas provides consumers with a convenient and cost - effective alternative to home delivery, take - away and eat - in restaurants.2
Producers and converters
of aluminum foil, plastic film and baking paper need to answer the demand
for direct
availability of their
products while ensuring best quality.
On Shelf
Availability is a key issue
for the consumer
products industry, as out -
of - stocks remain at an 8 percent average rate, according to joint research by The Trading Partner Alliance (TPA), an industry affairs leadership group formed by the Grocery Manufacturers Association (GMA) and Food Marketing Institute (FMI).
Due to the easy
availability of corn, sorghum, and quinoa,
product innovations
for bakery
products have been based on these gluten - free sources in the developed markets
of the U.S., Canada, Italy, and Germany.
In addition to leading the way
for other brands to begin removing toxins from their
products, this shift could likely impact the global supply market in upcoming years, increasing the
availability (and decreasing the cost)
of higher quality plant - based ingredients or safer chemicals that could be used in personal care
products across markets.
These linked sites are not under our control and we explicitly disclaim any responsibility
for the accuracy, content or
availability of the information
products, and / or services found on or through such third party sites.
However, wider challenges remain
for the sector, not just in terms
of rising raw material prices, but also in managing the volatility in the price and supply
of many key commodities, and ensuring the continuity
of supply when
product availability is short in the UK or globally.»
While the
availability of whey and lactose
products continue to climb during 2008, price volatility has managed to hamper hikes in profitability
of the segment as manufacturers hunt
for cheaper ingredients, says a new report.
The National Restaurant Association's 2014 Forecast indicates that
for six in 10 frequent fast - food diners — one
of the representative demographics purchasing the most battered and breaded food
products — the
availability of healthier menu items rank high as a decision - making factor
for choosing fast food.
Nutrition labels also create incentives
for food manufacturers to reformulate their
products, so helping populations more broadly by increasing the
availability of food
of higher nutritional value.
With more and more Australians deciding to make the ultimate choice
for animals and go meat - free, the
availability of alternatives to animal
products is on the rise.
Easier
availability of frozen foods has influenced the purchasing patterns
of consumer regarding dietary
products, rendering a firm place
for frozen foods in their list
of daily consumables.
Nevertheless, the finding that motivated food manufacturers improved their
products can be considered a positive starting point
for the improvement
of the
availability of healthy
products for consumers.
As the presenting sponsor
of the 14th Annual Waikiki SPAM JAM ® Festival, Outrigger Resorts and OHANA Hotels in Waikiki will be offering guests checking in
for the weekend a free one - category upgrade, based on
availability, with the donation
of a can
of SPAM ®
product, which is then donated to the Hawaii Foodbank.
One
of the biggest dairy - related stories to break this month was the announcement that as part
of their commitment to increase the
availability of healthy, American - made food
products in schools, the USDA is expanding its pilot program
for Greek - style yogurt
for the National School Lunch Program in SY 2014 - 15.
The Information on this Site is Provided «As Is»: Fertility Center
of Las Vegas and our suppliers disclaim all warranties and conditions, either express or implied, including, but not limited to, implied warranties
of merchantability, fitness
for a particular purpose, title, and non-infringement, with regard to the
products, services and information contained on or made available through this website, including but not limited to the
availability of this website, lack
of viruses, worms, Trojan horses or other code that manifest contaminating or destructive properties, or any failure to provide the service.
The market
for DIY
products and homemade works has never been better
for stay - at - home moms, particularly with the growing
availability of online resources.
You agree that momstown has no responsibility or liability
for the
availability of such external sites or resources, or
for the Content, advertising,
products, or other materials available through such sites or resources.
Denver, CO — Star Kids
Products today announced that it will be helping to solve the stresses
of family travel with the new nationwide
availability of its children's
product, The Snack and Play ™ Travel Tray, just in time
for the busiest family travel times
of the year.
SNA and its members are working with organizations such as The Whole Grains Council and The Grains
for Health Foundation to promote expanded
availability, affordability and quality
of whole grain
products for school meals programs.
The information is provided by Bay Area Soft Play and while we endeavour to keep the information up to date and correct, we make no representations or warranties
of any kind, express or implied, about the completeness, accuracy, reliability, suitability or
availability with respect to the website or the information,
products, services, or related graphics contained on the website
for any purpose.
These include: · Restricting trade hours
of on - licence venues to limit the
availability of alcohol in the early hours
of the morning · Enhancing community involvement, better facilitating the engagement
of local residents with licensing systems · Adding / prioritising public health and / or harm minimisation objectives in alcohol legislation · Restricting the sales
of high risk
products in areas
of concern; and · Deprioritising government support
for industry voluntary schemes in place
of policies supported by evidence.
The group would monitor the extent and complications
of opioid addiction; spread awareness
of symptoms and aftereffects through seminars and workshops; monitor and assess the state
of and improvements in treatment modalities; interface with manufacturers, retailers, and physicians offering
products to treat pain; pressure the medical community to reduce
availability of addictive analgesics and advocate
for nonaddictive substitutes, and maintain an interface between treatment programs and similar programs targeted at youth, health care, aging, and housing.
Annette Woolcock, development manager
for BASC's Taste
of Game game meat promotion campaign, said: «The growth enjoyed by game meat in recent years has largely stemmed from niche
products and increased
availability.